Study on the efficiency of virtual reality in the treatment of alcohol use disorder: study protocol for a randomized controlled trial : E-Reva.
Fanny Nègre, Maud Lemercier-Dugarin, Romain Gomet...
https://pubmed.ncbi.nlm.nih.gov/38937776Actively Recruiting
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-01-08
156
Participants Needed
1
Research Sites
139 weeks
Total Duration
Researchers are evaluating the effectiveness of virtual reality exposure therapy (VRET) combined with cognitive behavioral therapy (CBT) compared to CBT alone for adults with Alcohol Use Disorder (AUD). The study aims to see if this combination reduces alcohol consumption and craving 8 months after starting treatment. Participants must be abstinent for at least 15 days and diagnosed with AUD according to DSM-V criteria. The study will be conducted at four addiction day hospitals with follow-up lasting 8 months. All participants will first receive 4 weekly group CBT sessions during the first month after joining the study. Then, they will be randomly assigned to two groups: one receiving 4 weekly individual CBT sessions, and the other receiving 4 weekly VRET sessions during the second month. Each VRET session lasts 60 to 90 minutes and includes exposure to four different virtual environments, such as home, metro advertising, party, and supermarket settings, arranged by difficulty. Participants will be followed monthly for 6 months after the treatment period. During follow-up, researchers will track the participants' alcohol intake using the Timeline Follow-Back method and assess craving with the Transaddiction Craving Triggers Questionnaire. The main outcome measured is the cumulative number of standard alcohol drinks consumed monthly up to 8 months after inclusion. Safety and continued abstinence will also be monitored throughout the study.
CONDITIONS
Effectiveness of Virtual Reality Therapy in Alcohol Use Disorder Study
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Total: 1 location
1
Hôpital Albert Chenevier
Créteil, Île-de-France Region, France, 94000
Actively Recruiting
E
El-Hadi ZERDAZI, MD, PhD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fanny Nègre, Maud Lemercier-Dugarin, Romain Gomet...
https://pubmed.ncbi.nlm.nih.gov/38937776